Finance

Lists
MAYNF:OTCMKTS
Mayne Pharma Group Ltd
$2.35
0.00%
(0.00) 1D
Sep 1, 2:51:34 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MAYNF...
Mkt. cap
254.68M
Avg. vol.
1.51K
Volume
0.00
52-wk high
$4.00
52-wk low
$1.40
Beta
1.97
Shares outstanding
81.89M
No. of employees
363
Mkt. cap
254.68M
Avg. vol.
1.51K
Volume
0.00
52-wk high
$4.00
52-wk low
$1.40
Beta
1.97
Shares outstanding
81.89M
No. of employees
363
About Mayne Pharma Group Ltd
CEO-
Employees363
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitemaynepharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
106.04M
106.04M
85.80M
85.80M
Cost of goods sold
36.75M
36.75M
31.06M
31.06M
Cost of revenue
36.75M
36.75M
31.06M
31.06M
Research and development expenses
6.36M
6.36M
4.02M
4.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.70M
73.70M
53.25M
53.25M
Operating expense
80.05M
80.05M
57.27M
57.27M
Total operating expenses
116.80M
116.80M
88.32M
88.32M
Operating income
-10.76M
-10.76M
-2.52M
-2.52M
Other non operating income
-9.67M
-9.67M
-7.25M
-7.25M
EBT including unusual items
2.77M
2.77M
15.11M
15.11M
EBT excluding unusual items
-22.40M
-22.40M
-11.56M
-11.56M
Income tax expense
8.82M
8.82M
-6.54M
-6.54M
Effective tax rate
318.56%
318.56%
-43.28%
-43.28%
Other operating expenses
-
-
-
-
Net income
-7.47M
-7.47M
19.71M
19.71M
Net profit margin
-7.04%
-7.04%
22.97%
22.97%
Earnings per share
-
-
-
-
Interest and investment income
761.00K
761.00K
1.08M
1.08M
Interest expense
-1.31M
-1.31M
-1.35M
-1.35M
Net interest expenses
-546.00K
-546.00K
-267.50K
-267.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
5.09M
5.09M
11.46M
11.46M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps